+
Site Tour

Search

Showing 111 - 120 of 449 results.

  • Classification

    aThis algorithm can be applied to all patients with advanced HF defined according to the HFA-ESC criteria,5 with exception of hypertrophic cardiomyopathy (HCM), cardiac arrest (CA), arrhythmic storm
  • Overview

    HEART FAILURE IS AFFECTING A GROWING NUMBER OF PATIENTS With the complexity and rise in prevalence of heart failure, the Heart Failure Association of the European Society of Cardiology aims to make
  • Overview

    FIND OUT MORE: AMPLATZER™ DUCT OCCLUDERS   AMPLATZER™ PICCOLO™ OCCLUDER ABBOTT EVENTS PremiClose is the only worldwide symposium focused on PDA closure in preterm infants. The goal
  • Guidelines

    2024 EUROPEAN SOCIETY OF CARDIOLOGY (ESC) GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPED IN COLLABORATION WITH THE EUROPEAN ASSOCIATION OF CARDIOTHORACIC SURGERY (EACTS)4-7 ACCESS TO
  • Diagnosis

    AF AND STROKE ARE OFTEN CONNECTED MORE SEVERE FIND OUT MORE: PATIENTS WHO BENEFIT Clinical Data
  • Prevention

    AF AND THE CHALLENGES OF MEDICATION Many patients at risk of stroke want an alternative to oral anticoagulants (OACs), for example, warfarin and non-vitamin K oral anticoagulants (NOACs).7 40% Do N
  • Overview

    Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC Practice Guidelines for the Management of Patients with Atrial Fibrillation. Circulation. 2006;114(7):700–752. https://doi.org/10.1161/CIRCULATIO
  • Overview

    FIND OUT MORE: AMPLATZER™ TALISMAN™ PFO OCCLUDER PFO CLOSURE: BEHIND THE NUMBERS Ischemic strokes are of unknown cause5 Of patients with an ischemic stroke of unknown cause have a PFO4 P
  • Prevention

    PFO CLOSURE Closure of a PFO may prevent paradoxical embolism by preventing a venous thrombus from passing through the PFO and thereby reducing the risk of recurrent stroke. Evidence from the most re
  • Transcatheter Repair

    Topilsky Y, Maltais S, Medina Inojosa J et al. Burden of tricuspid regurgitation in patients diagnosed in the community setting. JACC Cardiovasc Imaging. 2019;12(3):433–442. https://doi.org/10.1016

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline